Literature DB >> 7964479

Interleukin 1 alpha activates two forms of p54 alpha mitogen-activated protein kinase in rabbit liver.

M Kracht1, O Truong, N F Totty, M Shiroo, J Saklatvala.   

Abstract

We have identified in rabbits two hepatic forms of T669 peptide kinases that are very strongly activated after systemic injection with the inflammatory cytokine interleukin 1 (IL-1). The T669 peptide contains a major phosphorylation site of the epidermal growth factor receptor, threonine 699 and is a substrate for mitogen-activated protein (MAP) kinases. The kinases were purified to homogeneity and corresponded to 50- and 55-kD proteins on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Amino acid sequencing of 12 tryptic peptides of both kinases identified them as p54 MAP kinase alpha. This kinase belongs to the novel family of stress-activated protein kinases. This is the first evidence of IL-1 activating a specific protein kinase in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7964479      PMCID: PMC2191785          DOI: 10.1084/jem.180.6.2017

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 3.  The mitogen-activated protein kinase signal transduction pathway.

Authors:  R J Davis
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

4.  pp54 microtubule-associated protein 2 kinase. A novel serine/threonine protein kinase regulated by phosphorylation and stimulated by poly-L-lysine.

Authors:  J M Kyriakis; J Avruch
Journal:  J Biol Chem       Date:  1990-10-05       Impact factor: 5.157

5.  Interleukin 1 signaling occurs exclusively via the type I receptor.

Authors:  J E Sims; M A Gayle; J L Slack; M R Alderson; T A Bird; J G Giri; F Colotta; F Re; A Mantovani; K Shanebeck
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

6.  Interleukin-1 represents a new modality for the activation of extracellular signal-regulated kinases/microtubule-associated protein-2 kinases.

Authors:  T A Bird; P R Sleath; P C deRoos; S K Dower; G D Virca
Journal:  J Biol Chem       Date:  1991-11-25       Impact factor: 5.157

7.  Interleukin-1 activates a novel protein kinase that phosphorylates the epidermal-growth-factor receptor peptide T669.

Authors:  M Kracht; M Shiroo; C J Marshall; J J Hsuan; J Saklatvala
Journal:  Biochem J       Date:  1994-09-15       Impact factor: 3.857

8.  Accelerated high-sensitivity microsequencing of proteins and peptides using a miniature reaction cartridge.

Authors:  N F Totty; M D Waterfield; J J Hsuan
Journal:  Protein Sci       Date:  1992-09       Impact factor: 6.725

9.  Phosphorylation of c-jun mediated by MAP kinases.

Authors:  B J Pulverer; J M Kyriakis; J Avruch; E Nikolakaki; J R Woodgett
Journal:  Nature       Date:  1991-10-17       Impact factor: 49.962

10.  The periodic association of MAP2 with brain microtubules in vitro.

Authors:  H Kim; L I Binder; J L Rosenbaum
Journal:  J Cell Biol       Date:  1979-02       Impact factor: 10.539

View more
  9 in total

1.  Analysis of mitogen-activated protein kinase pathways used by interleukin 1 in tissues in vivo: activation of hepatic c-Jun N-terminal kinases 1 and 2, and mitogen-activated protein kinase kinases 4 and 7.

Authors:  A Finch; W Davis; W G Carter; J Saklatvala
Journal:  Biochem J       Date:  2001-01-15       Impact factor: 3.857

2.  Synergistic activation of JNK/SAPK by interleukin-1 and platelet-derived growth factor is independent of Rac and Cdc42.

Authors:  W Davis; L R Stephens; P T Hawkins; J Saklatvala
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

3.  Staurosporine, but not Ro 31-8220, induces interleukin 2 production and synergizes with interleukin 1alpha in EL4 thymoma cells.

Authors:  T M Mahon; J S Matthews; L A O'Neill
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

4.  Protein synthesis inhibitors reveal differential regulation of mitogen-activated protein kinase and stress-activated protein kinase pathways that converge on Elk-1.

Authors:  R Zinck; M A Cahill; M Kracht; C Sachsenmaier; R A Hipskind; A Nordheim
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

5.  Interleukin-1 beta stimulates mitogen-activated protein kinase in U373 astrocytoma cells without the production of lipid second messengers.

Authors:  A K Utal; A L Stopka; P D Coleman
Journal:  Neurochem Res       Date:  1998-02       Impact factor: 3.996

6.  Interleukin 1-induced phosphorylation of MAD3, the major inhibitor of nuclear factor kappa B of HeLa cells. Interference in signalling by the proteinase inhibitors 3,4-dichloroisocoumarin and tosylphenylalanyl chloromethylketone.

Authors:  F Guesdon; T Ikebe; E Stylianou; J Warwick-Davies; S Haskill; J Saklatvala
Journal:  Biochem J       Date:  1995-04-01       Impact factor: 3.857

7.  c-Jun controls histone modifications, NF-kappaB recruitment, and RNA polymerase II function to activate the ccl2 gene.

Authors:  Sabine Wolter; Anneke Doerrie; Axel Weber; Heike Schneider; Elke Hoffmann; Juliane von der Ohe; Latifa Bakiri; Erwin F Wagner; Klaus Resch; Michael Kracht
Journal:  Mol Cell Biol       Date:  2008-04-28       Impact factor: 4.272

8.  The activation of distinct mitogen-activated protein kinase cascades is required for the stimulation of 2-deoxyglucose uptake by interleukin-1 and insulin-like growth factor-1 in KB cells.

Authors:  G W Gould; A Cuenda; F J Thomson; P Cohen
Journal:  Biochem J       Date:  1995-11-01       Impact factor: 3.857

9.  c-Jun N-terminal kinase phosphorylates DCP1a to control formation of P bodies.

Authors:  Katharina Rzeczkowski; Knut Beuerlein; Helmut Müller; Oliver Dittrich-Breiholz; Heike Schneider; Daniela Kettner-Buhrow; Helmut Holtmann; Michael Kracht
Journal:  J Cell Biol       Date:  2011-08-22       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.